Deep Femoral Vein, Posterior View

Description

Shown from the posterior aspect of the male thigh, the deep femoral vein (vena profunda femoris) courses proximally in the posterior compartment and ascends toward the femoral vein (vena femoralis) in the upper thigh. Tributaries from the hamstring region converge into the profunda system, including perforating veins accompanying the perforating branches of the profunda femoris artery as they pass from posterior to anterior through adductor magnus. More superficially, the small saphenous vein (vena saphena parva) tracks up the midline of the calf to meet the popliteal vein (vena poplitea) in the popliteal fossa, while venous channels in the leg and foot drain proximally into the popliteal and femoral pathways. Blue venous branching extends from the pelvis distally toward the feet. A dense network. For teaching posterior thigh venous anatomy, this view clarifies a point that is easy to miss in anterior diagrams, large-volume outflow from the hamstrings often reaches the femoral vein through the profunda femoris vein rather than through the superficial saphenous system. That distinction matters when mapping reflux or obstruction patterns, since profunda femoris tributaries can act as collateral pathways in femoropopliteal deep venous thrombosis or after femoral vein injury, and they influence how edema and venous claudication present. Surgical planning also benefits, as posterior perforators and profunda connections sit close to the adductor hiatus region where catheter placement, venous bypass, or trauma exposure may be considered. Use this artwork in gross anatomy and vascular modules when comparing superficial versus deep venous drainage of the lower limb, and in radiology or vascular surgery materials that pair venous Doppler, CT venography, or MR venography with posterior compartment landmarks. It also supports patient-facing education for deep vein thrombosis and chronic venous insufficiency when you need a clear map from calf to pelvis. Anatomical accuracy verified by SciePro's Medical Advisory Board.